Connection
Christopher Schneck to Depressive Disorder, Treatment-Resistant
This is a "connection" page, showing publications Christopher Schneck has written about Depressive Disorder, Treatment-Resistant.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.202 |
|
|
|
-
Niciu MJ, Meisner RC, Carr BR, Farooqui AA, Feifel D, Kaplin A, Kendrick EJ, Kim PM, Schneck CD, Vande Voort JL, Parikh SV. National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder. J Affect Disord. 2024 02 01; 346:221-222.
Score: 0.202